In this context, previous studies showed that HLA-G expression could be induced by 5-aza-2′-deoxycytidine and IFN-γ treatment in vitro in glioblastoma, and an enhanced peripheral sHLA-G level was observed in melanoma patients treated with IFN-α (113, 142). Here, IFNA2 is linked to melanoma.